Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03781063 |
|---|---|
| Brief Title: | Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation |
| First Submitted : | December 14, 2018 |
| First Submitted that Met QC Criteria : | December 17, 2018 |
| First Posted : | December 19, 2018 |
| Last Update Submitted that Met QC Criteria : | April 16, 2024 |
| Last Update Posted : | April 18, 2024 |